title: Clinically relevant concentrations of verapamil do not enhance the sensitivity of human bone marrow CFU-GM to adriamycin and VP16.
authors.affiliation: University Department of Haematology, Western Infirmary, Glasgow, UK.
authors.forename: M A
authors.initials: MA
authors.lastname: Smith
authors.forename: S
authors.initials: S
authors.lastname: Merry
authors.forename: J G
authors.initials: JG
authors.lastname: Smith
authors.forename: S B
authors.initials: SB
authors.lastname: Kaye
mesh_terms: D001853:Bone Marrow / Q000187:drug effects*; D001854:Bone Marrow Cells; D003114:Colony-Forming Units Assay; D004317:Doxorubicin / Q000494:pharmacology*; D004357:Drug Synergism; D005047:Etoposide / Q000494:pharmacology*; D006412:Hematopoietic Stem Cells / Q000187:drug effects*; D006801:Humans; D014700:Verapamil / Q000008:administration & dosage / Q000494:pharmacology*
chemical_list: D005047:Etoposide; D004317:Doxorubicin; D014700:Verapamil